| Botulinum Toxin Therapy in Hidradenitis Suppurativa (NCT05403710) | University of Massachusetts, Worcester | 2022-06-07 |
| Qbrexza Cloths for Hyperhidrosis of Amputation Sites (NCT04924036) | University of Utah | 2021-09-27 |
| Determination of Longus Colli Muscle Thickness by Ultrasonography (NCT05108103) | Istanbul University | 2021-03-01 |
| Laser Acupuncture Versus Tap Water Iontophoresis on Hyperhidrosis (NCT04862546) | Kafrelsheikh University | 2021-02-01 |
| Implementation of a Minor Ailment Service in Community Pharmacy Practice (NCT05247333) | Universidad de Granada | 2020-10-01 |
| An Open Label Study for Palmar Hyperhydrosis (NCT04906655) | Pariser, Robert J., M.D. | 2020-10-01 |
| Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis (NCT04263623) | Atacama Therapeutics | 2020-01-31 |
| Hyperhidrosis in Patients With Amputations-Botox (NCT03236012) | University of Utah | 2019-01-08 |
| Assessing the Effect of Patient Characteristics on Treatment Response in Primary Hyperhidrosis (NCT03694093) | St. Louis University | 2018-08-20 |
| Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2 (NCT03416348) | University of Utah | 2018-05-08 |
| Hyperhydrosis Treatment Using Botulinum Toxin (NCT03816046) | St Joseph University, Beirut, Lebanon | 2018-05-01 |
| Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers (NCT03647982) | Medy-Tox | 2018-03-20 |
| Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis (NCT04178161) | Massachusetts General Hospital | 2016-09-01 |
| Management of Palmar Hyperhidrosis With Hydrogel-based Iontophoresis (NCT02854540) | Stanford University | 2016-08-01 |
| T3-T4 Gray Sympathycotomy Versus Ramicotomy for Hyperhidrosis (NCT04721483) | University of Valencia | 2016-04-01 |
| A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis (NCT02682238) | Botanix Pharmaceuticals | 2016-03-08 |
| A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects (NCT02673619) | Stiefel, a GSK Company | 2016-03-07 |
| Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs) (NCT03433859) | Direction Centrale du Service de Santé des Armées | 2016-03-01 |
| A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults (NCT02633371) | University of Colorado, Denver | 2016-02-01 |
| Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis (NCT02099695) | Cristália Produtos Químicos Farmacêuticos Ltda. | 2015-12-01 |
| Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis (NCT02563899) | GlaxoSmithKline | 2015-11-23 |
| Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis (NCT02565732) | Revance Therapeutics, Inc. | 2015-09-01 |
| A Non-Interventional Study To Assess Sweating (NCT02552199) | Botanix Pharmaceuticals | 2015-09-01 |
| Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis (NCT02530294) | Journey Medical Corporation | 2015-08-01 |
| Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis (NCT02553798) | Journey Medical Corporation | 2015-08-01 |
| Study of Glycopyrronium in Axillary Hyperhydrosis (NCT02530281) | Journey Medical Corporation | 2015-07-01 |
| Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis (NCT02479139) | Allergan | 2015-06-03 |
| A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis (NCT02336503) | Botanix Pharmaceuticals | 2015-03-10 |
| The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis (NCT03203174) | University of California, Davis | 2015-01-01 |
| Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis (NCT02129660) | Journey Medical Corporation | 2014-04-01 |
| A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis (NCT02058264) | Botanix Pharmaceuticals | 2014-02-01 |
| Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis (NCT02193139) | Watson Pharmaceuticals | 2013-12-01 |
| A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis (NCT02016885) | Journey Medical Corporation | 2013-11-01 |
| Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects (NCT01934153) | GlaxoSmithKline | 2013-09-02 |
| Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis (NCT01930604) | Carl Swartling | 2013-09-01 |
| Treatment of Hyperhidrosis With Oxybutynin (NCT01855256) | University Hospital, Brest | 2013-06-01 |
| Evaluation of 1440nm Laser Assisted Selective Photothermolysis for Treatment of Axillary Hyperhidrosis (NCT02100072) | Cynosure, Inc. | 2013-06-01 |
| Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis (NCT01811004) | Cynosure, Inc. | 2012-09-01 |
| Histological Analysis Following Ulthera System Treatment for Hyperhidrosis (NCT01708551) | Ulthera, Inc | 2012-08-01 |
| Investigation of Hyperhidrosis Treatment Using the Nd: YAG 1440nm Wavelength Laser (NCT01810991) | Cynosure, Inc. | 2012-06-01 |
| Cardiac Autonomic Changes After Endoscopic Thoracic Sympathectomy For Essential Palmar Hyperhidrosis (NCT02733497) | University of Campania Luigi Vanvitelli | 2012-01-01 |
| Feasibility Study: Ulthera® System for the Treatment of Axillary Hyperhidrosis (NCT01713959) | Ulthera, Inc | 2011-08-01 |
| Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control Study (NCT01310712) | University of Sao Paulo | 2010-12-01 |
| GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis (NCT01128738) | GlaxoSmithKline | 2010-04-01 |
| Staged Extended Thoracoscopic Sympathicotomy for Palmo-axillo-plantar Hyperhidrosis (NCT02728297) | Mansoura University | 2010-01-01 |
| Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweating (NCT01671800) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2008-09-01 |
| Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea (NCT02043145) | Allergan | 2008-07-01 |
| Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis (NCT01956591) | Hospital Israelita Albert Einstein | 2007-09-01 |
| Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating (NCT00509886) | Northwestern University | 2007-06-01 |
| Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin (NCT00449683) | Thomas Jefferson University | 2007-03-01 |
| Objective Evaluation of Patients With Palmar Hyperhidrosis Submitted to Two Levels of Sympathectomy: T3 and T4. (NCT01140659) | University of Sao Paulo | 2007-02-01 |
| A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis (NCT00168415) | Allergan | 2005-08-01 |
| A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis (NCT00168402) | Allergan | 2002-02-01 |
| Study of Botulinum Toxin in Patients With Primary Hyperhidrosis (NCT00004480) | Icahn School of Medicine at Mount Sinai | 1999-07-01 |
| Liposuction as Treatment for Excessive Axillary Sweat (NCT00228072) | Odense University Hospital | |